Radiotherapy for prostate cancer in China typically costs from $14,500 to $31,500. The final price depends on the chosen technology, hospital classification, and case complexity. In the United States, similar treatments cost around $35,000 on average. Patients can find savings of approximately 34% in China. Packages usually include the radiation sessions, initial consultations, and treatment planning.
Bookimed Expert Insight: China offers high-value oncology care at JCI-accredited facilities like Fuda Cancer Hospital. This clinic specializes in treating advanced-stage cancer and uses unique minimally invasive alternatives. For radiotherapy, choosing a Class-III general hospital like Jinshazhou Hospital provides access to European-standard protocols. Their massive volume of 680,000 annual patients ensures high clinical expertise. International departments there provide multilingual support, making complex navigation much easier for foreign patients.
| China | Turkey | Austria | |
| Radiotherapy for prostate cancer | from $14,500 | from $4,000 | from $14,000 |
Day 1
Day 2
Day 3
Week 1
Week 2 - Week 7
Week 8
Week 9 - Week 12
Week 13
Please note that individual experiences may vary, and the above timeline is a general guide. Always consult your doctor for personalized advice.
The doctor is a renowned expert in minimally invasive cryosurgery for cancer, serving as President and chief surgeon at Fuda Cancer Hospital since 2001. With a focus on oncology and minimally invasive procedures, the doctor has performed nearly 10,000 cryosurgeries and 500 NanoKnife procedures, treating patients aged 4 to 94.
Graduating from The Fourth Military Medical University with a specialty in thoracic and cardiac surgery, the doctor has contributed significantly to the field with over 100 published papers. Recognized with awards for outstanding contributions to cryosurgery, the doctor holds vice-presidential roles in both the Asian and International Societies of Cryosurgery.
This procedure uses radiation to target and destroy cancer cells in the prostate gland.